GENTHERAXINE
BIOTHERA
Identification
- Active ingredient (INN)
- GENTAMICINE SULFATE EXPRIMEE EN GENTAMICINE
- Internal code
- 13 A 004
- Country of Origin
- Algeria
- Pharmaceutical form
- IM/IV Injectable Solution
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/05 ampoule de 02ml et b/50 ampoule de 02ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Associated Conditions
Lactation Corneal epithelium alteration Corticosteroid combination
Corneal Denervation Diabetes Child under 15 years of age Female likely to be pregnant Pregnancy, first 5 months (of) Lacrymal hyposecretion Eye infection Complex or repeated eye surgery Newborn exposed in utero to the medicine Rheumatoid arthritis Subject at risk of infection Subject at risk of bleeding Subject with contact lenses Concomitant treatment with medicinal products that disrupts the haemogram Concomitant treatment with eye drops Extended treatment.
Mechanism of Action
Mechanism of action
Indometacin is a nonsteroidal anti-inflammatory drug belonging to the group of indolics, and has the following properties: analgesic, anti-inflammatory, antipyretic and platelet function inhibition.
All of these properties are related to inhibition of prostaglandin synthesis.
Adverse Effects
- Photosensitivity (Rare)
- Hypersensitivity (Rare)
- Eye irritation (Uncommon)
- Eye pain (Uncommon)
- Eye pruritus (Rare)
- Keratite punctuated (Rare)
- Eye redness (Rare)
- Corneal ulcer Keratite
- Eye hyperaemia Corneal edema Lacrimal hypersecretion Visual defects Corneal perforation
- Conjunctival hyperaemia Palpebral edema.